Patents by Inventor Meiling Li

Meiling Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250389965
    Abstract: Disclosed are a smart head mount device and a housing thereof. The housing comprises a weight-reducing frame by at least a part of the housing The weight-reducing frame is made of at least an organic aerogel material and has a density of 0.4 g/cm3 to 1.3 g/cm3 and a bending modulus greater than 2.5 GPa.
    Type: Application
    Filed: March 9, 2023
    Publication date: December 25, 2025
    Applicant: Goertek Inc.
    Inventors: Meiling LI, Chun Li, Fengguang Ling
  • Publication number: 20250376684
    Abstract: Described are antisense oligonucleotides comprising one or more ?-L-threofuranosyl (TNA) nucleosides linked to an adjacent nucleoside via a phosphodiester (PO) internucleoside linkage, as well as methods to modulate the properties of antisense oligonucleotides by the introduction of such TNA nucleosides. These are particularly applicable to antisense gapmer oligonucleotides.
    Type: Application
    Filed: February 26, 2025
    Publication date: December 11, 2025
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: Jessica Marine Aurore BASTIEN, Konrad BLEICHER, Helle CHRISTIANSEN, Lukasz KIELPINSKI, Erich KOLLER, Meiling LI, Michael OTTENEDER, Adrian SCHAEUBLIN, Steffen SCHMIDT, Sabine SEWING
  • Publication number: 20250290068
    Abstract: The present invention relates to antisense oligonucleotides which are complementary to conserved TDP-43 binding sites on pre-mRNA transcripts, which are capable of restoring RNA binding protein function in the processing of multiple independent mRNAs in TDP-43 depleted cells.
    Type: Application
    Filed: November 15, 2024
    Publication date: September 18, 2025
    Inventors: Jessica Marine Aurore BASTIEN, Katarzyna CHYZYNSKA, Lars JOENSON, Meiling LI, Bettina NORDBO, Jonas VIKESAA
  • Publication number: 20250203291
    Abstract: Disclosed in the present disclosure are a dome and a diaphragm assembly for a sound producing apparatus, a sound producing apparatus, and an electronic device. The dome comprises an organic aerogel matrix and a reinforcing material dispersed in the organic aerogel matrix. The mass of the organic aerogel matrix accounts for 10% to 95% of the total mass of the dome, and the modulus density ratio of the dome is greater than or equal to 5 GPa·cm3/g. According to the present disclosure, the dome has a light weight, and thus facilitates meeting the design requirements of lightening, thinning and miniaturization of the sound producing apparatus, and can also reduce the resonance frequency of the sound producing apparatus and improve the medium-frequency sensitivity thereof.
    Type: Application
    Filed: February 24, 2023
    Publication date: June 19, 2025
    Inventors: Haitao ZHANG, Meiling LI, Chun LI, Chunfa LIU, Chengfei ZHANG
  • Publication number: 20250175725
    Abstract: A housing of a sound generating device, the sound generating device and an electronic apparatus are provided. At least a part of the housing of the sound generating device is formed as a supporting part, at least a part of the supporting part is made of organic aerogel material, the organic aerogel material has a mesh structure on which reinforcement material is distributed, the reinforcement material accounts for 0 wt % to 40 wt % of the supporting part, and a specific modulus of the supporting part is 1.5 GPa·cm3/g to 40 GPa·cm3/g. At least part of the housing of the sound generating device is formed as the supporting part, the supporting part including organic aerogel material with a mesh structure and reinforcement material disposed on the mesh structure. Thus, the housing of the sound generating device has advantages of high strength, light weight and strong applicability.
    Type: Application
    Filed: February 24, 2023
    Publication date: May 29, 2025
    Inventors: Haitao ZHANG, Meiling LI, Chun LI, Chengfei ZHANG, Chunfa LIU
  • Publication number: 20250175735
    Abstract: A housing of a sound production device, a sound production device, and an electronic apparatus. At least a part of the housing is a first support housing, and the first support housing includes a metal frame and an organic aerogel material, wherein the metal frame is a porous framework with a pore channel structure, and the organic aerogel material is distributed on a surface of the metal frame and in the pore channel structure.
    Type: Application
    Filed: February 24, 2023
    Publication date: May 29, 2025
    Inventors: Chunfa LIU, Cuicui WANG, Meiling LI, Chun LI
  • Publication number: 20250145996
    Abstract: The present invention relates to antisense oligonucleotides which are complementary to conserved TDP-43 binding sites on pre-mRNA transcripts, which are capable of restoring RNA binding protein function in the processing of multiple independent mRNAs in TDP-43 depleted cells. The contiguous nucleotide sequence of the antisense oligonucleotides comprise 2?-O-methoxyethyl-RNA (2?-MOE) nucleosides and the antisense oligonucleotides are attached to cholesterol moieties.
    Type: Application
    Filed: November 15, 2024
    Publication date: May 8, 2025
    Inventors: Jessica Marine Aurore BASTIEN, Katarzyna CHYZYNSKA, Lars JOENSON, Meiling LI, Bettina NORDBO, Jonas VIKESAA
  • Publication number: 20250034576
    Abstract: The present invention relates to double stranded oligonucleotides that are complementary to JAK1, leading to modulation of the expression of JAK1. Modulation of JAK1 expression is beneficial for a range of medical disorders including inflammatory bowel disease, organ transplant rejection, graft-versus-host disease, multiple sclerosis, rheumatoid arthritis (RA), juvenile idiopathic arthritis, psoriasis, dermatitis, diabetic nephropathy, systemic lupus erythematosus (SLE), dry eye disease, cancer, myelofibrosis, and asthma. Also included are compositions comprising the double stranded oligonucleotide and methods of treatment using the double stranded oligonucleotide.
    Type: Application
    Filed: June 14, 2024
    Publication date: January 30, 2025
    Inventors: Philipp Friedrich BERNINGER, Konrad BLEICHER, Erik FUNDER, Helle JACOBSEN, Dennis Jul HANSEN, Michael KELLER, Inna Appeldorff LARSEN, Meiling LI, Disa Elisabet TEHLER, Lotte WINTHER, Jesper WORM, Lena WYSS, Tiago Francisco SANTOS FERREIRA
  • Publication number: 20240405805
    Abstract: A wireless secure communication method based on RIS-NOMA under complex channel conditions, the method including: firstly, an intelligent surface is assume to be disposed between the base station and legitimate NOMA users, and between the base station and eavesdroppers; the signal to interference plus distortion noise ratio (SIDNR) for the legitimate NOMA user and the eavesdropper is calculated in the presence of RHI in the system; secondly, considering shadow fading and to simplify the overly complex calculation process, the probability density function and cumulative distribution function of the shadow fading are approximated; finally, the outrage probability and intercept probability of the legitimate users and eavesdroppers are calculated.
    Type: Application
    Filed: March 19, 2024
    Publication date: December 5, 2024
    Inventors: Meiling LI, Ruifen MA, Zhaoming LU, Heyong HAN, Chang LIU
  • Publication number: 20240368593
    Abstract: The present invention relates to a gapmer oligonucleotide comprising at least one phosphorodithioate internucleoside linkage of formula (I) as defined in the description and in the claims. The oligonucleotide of the invention can be used as a medicement.
    Type: Application
    Filed: March 27, 2024
    Publication date: November 7, 2024
    Applicant: Roche Innovation Center Copenhagen A/S
    Inventors: Konrad Bleicher, Joerg Duschmalé, Martina Brigitte Duschmalé, Henrik Frydenlund Hansen, Erik Funder, Troels Koch, Meiling Li, Adrian Schaeublin, Xi Shu, Yong Wu
  • Publication number: 20240336920
    Abstract: Described are antisense oligonucleotides comprising one or more ?-L-threofuranosyl (TNA) nucleosides as well as methods to modulate the properties of antisense oligonucleotides by the introduction of TNA nucleosides. These are particularly applicable for antisense gapmer oligonucleotides.
    Type: Application
    Filed: June 20, 2024
    Publication date: October 10, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jessica Marine Aurore BASTIEN, Konrad BLEICHER, Helle CHRISTIANSEN, Erich KOLLER, Meiling LI, Helle NYMARK, Adrian SCHAEUBLIN, Steffen SCHMIDT
  • Publication number: 20240327837
    Abstract: The present invention relates to antisense oligonucleotides which are complementary to conserved TDP-43 binding sites on pre-mRNA transcripts, which are capable of restoring RNA binding protein function in the processing of multiple independent mRNAs in TDP-43 depleted cells.
    Type: Application
    Filed: February 7, 2024
    Publication date: October 3, 2024
    Inventors: Congwei WANG, Christian WEILE, Martin EBELING, Lars JOENSON, Jonas VIKESAA, Ravi JAGASIA, Meiling LI
  • Patent number: 12084657
    Abstract: The present invention relates to antisense oligonucleotides which are complementary to conserved TDP-43 binding sites on pre-mRNA transcripts, which are capable of restoring RNA binding protein function in the processing of multiple independent mRNAs in TDP-43 depleted cells.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: September 10, 2024
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Congwei Wang, Christian Weile, Martin Ebeling, Lars Joenson, Jonas Vikesaa, Ravi Jagasia, Meiling Li
  • Patent number: 11597926
    Abstract: The present invention relates to a compound of formula (II) or (IIb) Wherein X, Y, Rx, Ry, R5 and Nu are as defined in the description and in the claims. The compound of formula (II) can be used in the manufacture of oligonucleotides.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: March 7, 2023
    Assignee: ROCHE INNOVATION CENTER COPENHAGEN A/S
    Inventors: Konrad Bleicher, Joerg Duschmalé, Martina Brigitte Duschmalé, Henrik Frydenlund Hansen, Troels Koch, Meiling Li, Adrian Schaeublin, Xi Shu, Yong Wu
  • Publication number: 20230002762
    Abstract: The present invention relates to an oligonucleotide comprising at least one phosphorodithioate internucleoside linkage of formula (I) (I) as defined in the description and in the claim. The oligonucleotide of the invention can be used as a medicement.
    Type: Application
    Filed: April 14, 2022
    Publication date: January 5, 2023
    Applicant: ROCHE INNOVATION CENTER COPENHAGEN A/S
    Inventors: Konrad Bleicher, Henrik Frydenlund HANSEN, Troels KOCH, Jesper WORM, Adrian SCHAEUBLIN, Erik FUNDER, Joerg DUSCHMALÉ, Lars JOENSON, Meiling LI, Martina Brigitte DUSCHMALÉ, Yong WU, Xi SHU
  • Publication number: 20220033818
    Abstract: The present invention relates to antisense oligonucleotides which are complementary to conserved TDP-43 binding sites on pre-mRNA transcripts, which are capable of restoring RNA binding protein function in the processing of multiple independent mRNAs in TDP-43 depleted cells.
    Type: Application
    Filed: July 23, 2021
    Publication date: February 3, 2022
    Inventors: Congwei WANG, Christian WEILE, Martin EBELING, Lars JOENSON, Jonas VIKESAA, Ravi JAGASIA, Meiling LI
  • Publication number: 20210292358
    Abstract: The present invention relates to an oligonucleotide comprising at least one phosphorotrithioa to internucleoside linkage of formula (I), wherein (A1), (A2) and R are as defined in the description and in the claim. The oligonucleotide of the invention can be used as a medicament.
    Type: Application
    Filed: July 30, 2019
    Publication date: September 23, 2021
    Applicant: Roche Innovation Center Copenhagen A/S
    Inventors: Konrad Bleicher, Troels KOCH, Adrian SCHAEUBLIN, Joerg Jakob Andreas DUSCHMALE, Martina Brigitte DUSCHMALE, Meiling LI, Erich KOLLER
  • Publication number: 20210221837
    Abstract: The present invention relates to an oligonucleotide comprising at least one phosphorotrithioate internucleoside linkage of formula (I) as defined herein. The oligonucleotide of the invention can be used as a medicament.
    Type: Application
    Filed: July 29, 2019
    Publication date: July 22, 2021
    Applicant: Roche Innovation Center Copenhagen A/S
    Inventors: Konrad BLEICHER, Joerg Jakob Andreas DUSCHMALÉ, Martina Brigitte DUSCHMALÉ, Troels KOCH, Erich KOLLER, Meiling LI, Adrian SCHAEUBLIN
  • Publication number: 20210115438
    Abstract: The present invention relates to a compound of formula (II) or (IIb) Wherein X, Y, Rx, Ry, R5 and Nu are as defined in the description and in the claims. The compound of formula (II) can be used in the manufacture of oligonucleotides.
    Type: Application
    Filed: December 21, 2018
    Publication date: April 22, 2021
    Applicant: ROCHE INNOVATION CENTER COPENHAGEN A/S
    Inventors: Konrad BLEICHER, Joerg DUSCHMALÉ, Martina Brigitte DUSCHMALÉ, Henrik Frydenlund HANSEN, Troels KOCH, Meiling LI, Adrian SCHAEUBLIN, Xi SHU, Yong WU
  • Patent number: 10927023
    Abstract: A method may add whey to high calcium papermaking industrial wastewater blended and pre-acidification treatment to promote anaerobic reaction and inhibit calcification. The method includes, before anaerobic treatment of papermaking wastewater, mixing whey wastewater with the papermaking wastewater. The method also includes pre-treating the papermaking wastewater by acidification to stabilize the papermaking wastewater prior to entering an anaerobic reaction system.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: February 23, 2021
    Inventors: Shuangfei Wang, Zhiwei Wang, Hui Liu, Chengrong Qin, Chen Liang, Xueping Song, Lianxin Luo, Xinliang Liu, Meiling Li